Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience.
Marco LoffiValentina RegazzoniMarco ToselliAlberto CeredaAnna PalmisanoDavide VignaleFrancesco MoroniGianluca PontoneDaniele AndreiniElisabetta Maria ManciniAlberto MonelloGianmarco IannopolloGianni CasellaFrancesco MonettiLorenzo MontiGiuseppe FerrilloGaetano LiccardoElisabetta TonetOttavio ZucchettiAlberto CossuMarco DugoGianluigi PatelliPietro SergioAntonio EspositoAntonio ColomboFrancesco GianniniRaffaele PiccoloGian Battista DanziPublished in: PloS one (2021)
Despite a low rate of risk factors for venous thromboembolism, PE is present in about 1 out 3 patients with SARS-CoV-2 pneumonia undergoing CTPA for inadequate response to oxygen therapy, elevated D-dimer level, or echocardiographic signs of right ventricular dysfunction. In most of the cases, the thromboses were located distally in the pulmonary tree and were mainly confined within pneumonia areas.
Keyphrases
- sars cov
- pulmonary embolism
- respiratory failure
- venous thromboembolism
- pulmonary hypertension
- respiratory syndrome coronavirus
- inferior vena cava
- liver failure
- community acquired pneumonia
- left ventricular
- risk factors
- extracorporeal membrane oxygenation
- oxidative stress
- mitral valve
- stem cells
- left atrial
- drug induced
- mesenchymal stem cells
- aortic dissection
- bone marrow
- ejection fraction
- cell therapy